BCWORLD PHARM. Statistics

Total Valuation

BCWORLD PHARM. has a market cap or net worth of KRW 39.58 billion. The enterprise value is 120.44 billion.

Market Cap	39.58B
Enterprise Value	120.44B

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

BCWORLD PHARM. has 8.44 million shares outstanding. The number of shares has increased by 0.25% in one year.

Current Share Class	8.44M
Shares Outstanding	8.44M
Shares Change (YoY)	+0.25%
Shares Change (QoQ)	-0.61%
Owned by Insiders (%)	47.31%
Owned by Institutions (%)	n/a
Float	4.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.51
PB Ratio	0.55
P/TBV Ratio	0.57
P/FCF Ratio	63.17
P/OCF Ratio	9.61
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.86, with an EV/FCF ratio of 192.25.

EV / Earnings	-31.99
EV / Sales	1.56
EV / EBITDA	10.86
EV / EBIT	37.14
EV / FCF	192.25

Financial Position

The company has a current ratio of 0.52, with a Debt / Equity ratio of 1.22.

Current Ratio	0.52
Quick Ratio	0.29
Debt / Equity	1.22
Debt / EBITDA	7.95
Debt / FCF	140.81
Interest Coverage	0.76

Financial Efficiency

Return on equity (ROE) is -2.94% and return on invested capital (ROIC) is 1.26%.

Return on Equity (ROE)	-2.94%
Return on Assets (ROA)	1.17%
Return on Invested Capital (ROIC)	1.26%
Return on Capital Employed (ROCE)	3.72%
Revenue Per Employee	275.16M
Profits Per Employee	-13.44M
Employee Count	280
Asset Turnover	0.45
Inventory Turnover	2.62

Taxes

In the past 12 months, BCWORLD PHARM. has paid 592.94 million in taxes.

Income Tax	592.94M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.98% in the last 52 weeks. The beta is 0.73, so BCWORLD PHARM.'s price volatility has been lower than the market average.

Beta (5Y)	0.73
52-Week Price Change	+28.98%
50-Day Moving Average	4,635.10
200-Day Moving Average	4,555.35
Relative Strength Index (RSI)	57.18
Average Volume (20 Days)	10,462

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BCWORLD PHARM. had revenue of KRW 77.04 billion and -3.76 billion in losses. Loss per share was -404.86.

Revenue	77.04B
Gross Profit	31.19B
Operating Income	3.24B
Pretax Income	-1.57B
Net Income	-3.76B
EBITDA	11.09B
EBIT	3.24B
Loss Per Share	-404.86

Full Income Statement

Balance Sheet

The company has 7.59 billion in cash and 88.22 billion in debt, giving a net cash position of -80.63 billion or -9,554.95 per share.

Cash & Cash Equivalents	7.59B
Total Debt	88.22B
Net Cash	-80.63B
Net Cash Per Share	-9,554.95
Equity (Book Value)	72.50B
Book Value Per Share	7,793.63
Working Capital	-41.34B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.12 billion and capital expenditures -3.49 billion, giving a free cash flow of 626.48 million.

Operating Cash Flow	4.12B
Capital Expenditures	-3.49B
Free Cash Flow	626.48M
FCF Per Share	74.24

Full Cash Flow Statement

Margins

Gross margin is 40.49%, with operating and profit margins of 4.21% and -4.89%.

Gross Margin	40.49%
Operating Margin	4.21%
Pretax Margin	-2.04%
Profit Margin	-4.89%
EBITDA Margin	14.40%
EBIT Margin	4.21%
FCF Margin	0.81%

Dividends & Yields

This stock pays an annual dividend of 90.91, which amounts to a dividend yield of 1.94%.

Dividend Per Share	90.91
Dividend Yield	1.94%
Dividend Growth (YoY)	10.00%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.25%
Shareholder Yield	1.69%
Earnings Yield	-9.51%
FCF Yield	1.58%

Dividend Details

Stock Splits

The last stock split was on December 27, 2024. It was a forward split with a ratio of 1.1.

Last Split Date	Dec 27, 2024
Split Type	Forward
Split Ratio	1.1

Scores

BCWORLD PHARM. has an Altman Z-Score of 0.76 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.76
Piotroski F-Score	7